The Skolkovo Foundation has signed a cooperation agreement with Janssen, a Belgium-headquartered subdivision of U.S. pharma giant Johnson & Johnson, with the aim of boosting innovative pharmaceutical research, including through financial support. Priority...
SL Onkolodzhi , a Skolkovo resident startup working on a cancer vaccine, has successfully completed phase I/IIa clinical trials together with its U.S. partner, CureLab Oncology, Inc . The two companies have developed a cancer vaccine called Elenagen™...
Infectex , a resident of the Skolkovo Foundation’s biomed cluster, has completed clinical trials in Russia of its new drug for treating TB, the company announced on Friday, World Tuberculosis Day. The drug – SQ109 – has demonstrated high...
The Skolkovo Foundation has signed a cooperation agreement with BioCubaFarma, Cuba’s biggest biotech company, continuing a series of agreements and mutual visits between the foundation and the island nation. Prime Minister Dmitry Medvedev, right...
Finland’s BioCity Technopark is to build a biotech technopark at the Skolkovo innovation centre under an agreement signed Tuesday at the ongoing International Association of Science Parks and Areas of Innovation (IASP) conference in Moscow. Kirill...
3D Bioprinting Solutions , a resident company of the Skolkovo Foundation that made headlines last year when it printed the world’s first functional thyroid construct for a mouse, is to make a 3D bioprinter for printing tissue and organ constructs on board...